How to Handle Muscle Pains When Starting a New Exercise Routine 

Are you a couch potato transforming into a gym rat? You have probably noticed that your muscles are pretty sore since increasing your activity level. Moving your muscles in new ways causes small tears to the muscle fibers, which leads to aching and tenderness hours after your workout. The good news is that you don't have to play through the pain. Here are four ways to handle muscle pains when starting a new exercise routine.

Stretch Before and After

One of the easiest and most effective ways to prevent muscle pain is to stretch before and after your workout. A good stretching routine helps to loosen muscle fibers and prevent the tearing that leads to soreness. Try to stretch for at least ten minutes at the beginning and end of your exercise routine, and focus on one part of the body at a time to ensure that each muscle is thoroughly stretched.

Consult a Doctor

Remember when you had to get a physical to play sports in school? Seeing a sports medicine doctor before beginning a new workout routine is still a good idea. The doctor can let you know if there is any reason to avoid starting a new exercise routine or if you should modify your workouts. They can also advise you on injury prevention and prescribe any medication or equipment you may need. Those who specialize in sports medicine are most likely to be able to quickly recognize the causes of your aches and pains.

Stay Hydrated

Did you know that dehydration can increase muscle soreness after a workout? Water is necessary to maintain your body's electrolyte balance and flush out the lactic acid that builds up in your muscles during exercise. If you're working out hard, water may not be enough to stay properly hydrated. Consider using a sports drink or adding electrolyte tablets to your water bottle for extra hydration.

Take Supplements

Muscle soreness and cramps can be exacerbated by nutritional deficiencies, and working out depletes your nutrient stores much faster than sitting on the couch. Having a protein shake after your workout can prevent sore muscles by helping to rebuild the fibers, and turmeric can soothe inflammation better than ibuprofen. Are charley horses putting a cramp in your routine? Try taking a magnesium supplement once or twice a day.

If your muscle pain is severe or persistent, consider slowing down your workouts or taking a rest for a few days. You might think you can walk it off, but continuing to exercise on a very painful muscle can lead to serious sprains that require medical intervention. 

The WiseGuide App: Gain Confidence, Find Happiness and Achieve Success

Fort Myers, FL, July 9, 2021 — Effective Learning Systems, the company that pioneered the practice of Productive Meditation more than 45 years ago, recently announced the launch of their first mobile app, WiseGuide, putting the company’s entire library of powerful, time-tested self-improvement techniques at everyone’s fingertips.

WiseGuide goes beyond the benefits of traditional mindfulness and meditation teachings to deliver a vast library of targeted, impactful programs that can help users achieve specific, life-changing personal and professional goals, including boosting athletic performance, building healthier relationships, cultivating better concentration and managing addictions. 

“Most people experience positive results immediately and remarkable life-transformation with regular, consistent use,” said Effective Learning Systems founder Bob Griswold.

Features of the WiseGuide App include:

- Over 120 prescriptive titles that address specific goals, including smoking cessation, weight control, stress management, better sleep and much more 

- A children’s collection for self-image and self-esteem

- Effective studying and test taking for children from grade school through college

- Programs to listen to while driving, exercising, working or even sleeping

- Works on any iOS or Android mobile device

It is never too late to break bad habits, overcome fears, manage stress or improve virtually any other aspect of life, and it’s never been easier. The WiseGuide App can help people use the power of their own minds to take control and make lasting improvements. And all they have to do is listen.

The WiseGuide App was developed by Effective Learning Systems, whose founder Bob Griswold has been helping people harness the power of their own minds to make transformative changes for more than 45 years. His unique approach to meditation, guided imagery, positive affirmations, relaxation, self-hypnosis and more make his programs uniquely effective. 

For more information or to download the app, please visit www.thewiseguideapp.com or www.effectivelearning.com

Sign Heralding Jesus’ Second Coming will be Written in the Sky

Orlando, FL, July 9, 2021 ― The High Sign, from Bible scholar David S. Heeren, compellingly reveals 200 points of evidence involving 24 scriptural events that support his unconventional interpretation of the Bible’s end time prophecy. 

For 13 years, Heeren has been compiling Scriptures as well as information from independent sources containing similar prophetic imagery. Over time, his confidence in his predication has grown, and today he is more convinced than ever that he has identified the celestial event that will signal Jesus’ return.

His investigation began after reading the book of Isaiah, which describes great visions given supernaturally to the prophet, including many about the Day of the Lord. It was after reading Isaiah and praying Isaiah’s prayer: “Here am I, send me,” when the meaning of many biblical passages began to crystalize for Heeren, and the message of The High Sign started taking shape. 

“The next day, I started perceiving a pattern in Isaiah’s prophetic imagery looking beyond the life of Jesus on earth to the era of his prophesied Second Coming on what the Bible refers to as the Day of the Lord,” Heeren says. “This was a noteworthy first for me because for a half-century before then, I had read biblical prophecies with great fascination but negligible understanding. Suddenly, I was beginning to make sense of some of the Bible’s most mysterious passages.”

He found 54 prophetic images, and the evidence mounted concerning the identity of the celestial sign of Jesus' Second Coming, until there were more than 200 individual points leading Heeren to arrive at a conclusion few, if any, theologians have reached as yet.

“There is not a single contradictory point of evidenceat least none that I found, and I have studied this specific subject now for 16 years,” he adds. 

Heeren also explores in detail the Flood of Noah, the demolition of Sodom, the plagues of the Exodus, and the arrival and Second Coming of Christ — and how astronomical events are tied to each. To help readers recall his main ideas, Heeren provides summarization points at the end of each chapter, and concludes his book with a list of seven things for Christians to do to prepare for the Day of the Lord.

David S. Heeren is an award-winning journalist and author of 17 books. He used his background in mathematics and logic to create Tendex, the first internationally used statistical system for rating professional and college basketball players. Nine of his books have Christian themes, including the Online Book Club Book of the Day The High Sign, Day of the LordWhat the Bible has to Say about the U.S.A., The Sign of His Coming and God…or not? To learn more, please visit: www.endtimesmystery.com.

The High Sign

Publisher: URLink Print & Media, LLC 

ISBN-10: 1647531586

ISBN-13: 978-1647531584

Available from Amazon.com

Expert Speaker and Brain Health Doctor Addresses Worsening Pandemic-Related Mental Challenges

Chattanooga, TN, July 7, 2021 ― Forced social isolation and shuttered businesses have led to an alarming rise in anxiety, depression, suicide and other mental health challenges. As we search for a clear path toward physical and mental recovery, one world-renowned doctor is uniquely poised to address the very serious subject of brain health from both scientific and spiritual perspectives — a much needed and welcomed approach during these extremely distressing times.

Timothy R. Jennings, M.D., is a board-certified psychiatrist, master psychopharmacologist, lecturer and renowned international speaker. He is also the founder of Come and Reason Ministries and uses his understanding of the Bible and how it relates to our modern world to inform his approach to brain health and overall wellbeing. 

Dr. Jennings expertly weaves spirituality with brain science to address fear, depression, anxiety and relationship issues. He recently explored at length the damaging effects of social isolation (https://comeandreason.com/index.php/en/blogs-main/903-social-isolation-during-covid-19) and its profound impact on physical and mental health, particularly for those already suffering from chronic conditions. 

He is a much sought-after speaker who regularly addresses non-medical professionals on the subjects of Spirituality in Medicine, Depression and its Spiritual and Physical Connections, and Alzheimer’s Dementia. He also speaks to medical professionals on the topics of Psychotherapy in Clinical Practice, Major Depression in the Primary Care Setting, and the Neurobiology of Depression — among many others. 

Dr. Jennings operates a private practice in Chattanooga and has successfully treated thousands of patients. He is a Distinguished Fellow of the American Psychiatric Association and Life-Fellow of the Southern Psychiatric Association. 

He is also a prolific author whose books include The God-Shaped Brain: How Changing Your View of God Transforms Your Life; Could It Be This Simple? A Biblical Model for Healing the MindThe Aging Brain: Proven Steps to Prevent Dementia and Sharpen Your Mind; and The God-Shaped Heart: How Correctly Understanding God’s Love Transforms Us.

To hear his presentations and to learn more about Dr. Timothy R. Jennings and his approach to brain and body health, please visit: www.comeandreason.com.

Opioid Deaths Continue to Rise as Cities Reopen

Baltimore, MD, July 7, 2021 — Tens of thousands of American lives end prematurely every year due to opioid overdoses, leaving families shattered. Dr. Paul Christo, an Associate Professor in the Division of Pain Medicine at the Johns Hopkins University School of Medicine, wants to remind those battling addiction to make use of telemedicine and tele-mental health services that emerged as valuable resources during the pandemic, and he adds, clinicians need to advocate to their patients that online treatment options are available. 

Dr. Christo, who is on the frontlines working to curb the impact of the opioid crisis, also wants patients to know that critical medications for maintaining sobriety can now be prescribed by telehealth or telephone.

"The number of fatalities from opioid-related overdoses could be nearly 30 percent higher than reported due to missing information or incomplete death records,” he says. “The worst fear is that because of social isolation, people are not being found or treated immediately."

The opioid epidemic today progressed in three phases, according to the Centers for Disease Control and Prevention. The first involves deaths caused by prescription opioids, the second, an increase in heroin use, and the third, a surge in the use of synthetic opioids or fentanyl. Experts say the U.S. is right in the middle of the third phase of the epidemic, due to the increasing availability of fentanyl and increasing rates of overdose deaths involving synthetic opioids.

According to a recent study there were 632,331 drug overdoses between 1999 and 2016. Most of these deaths (78.2 percent) were drug overdoses with known drug classification. Moreover, 21.8 percent were unclassified drug overdoses. A further investigation revealed that for unclassified drug overdoses, 71.8 percent involved opioids, translating to 99,160 additional opioid-related deaths.

There were over 70,000 drug overdose deaths in 2017, according to an estimate from the CDC. Based on findings from the new study, over half of those deaths — about 47,000 — are suspected of having involved opioids.

Another study on opioid overdoses found that the number of drug overdose deaths decreased by 4 percent from 2017 to 2018. In 2018, more than 67,000 people died from drug overdoses, making it a leading cause of injury-related death in the United States. Almost 70 percent involved a prescription or illicit opioid of those deaths.

“COVID 19 impacted the drug supply chain by closing borders on some regions, and it led to the higher death rate,” Dr. Christo explained. He added that drugs become more challenging to get, and the potency of overdose goes up. It also impacts the price, everything goes up, and in that sense, it becomes more deadly each day, according to Dr. Christo.

About Dr. Paul Christo 

Dr. Paul Christo serves as Director of the Multidisciplinary Pain Fellowship Program at Johns Hopkins Hospital. He is the author of Aches and Gains, A Comprehensive Guide to Overcoming Your Pain. Dr. Paul Christo also hosts an award-winning, nationally syndicated SIRIUS XM radio talk show on overcoming pain called, Aches and Gains®. For more information about Dr. Paul Christo. Please visit www.paulchristomd.com.

###

TELUS and Cool Aid bring innovative Health for Good™ mobile health clinic to Victoria

The Cool Aid Mobile Health Clinic, powered by TELUS Health, is a specially-equipped mobile van providing primary healthcare to marginalized people in the Capital region

VICTORIA, British Columbia, July 07, 2021 (GLOBE NEWSWIRE) -- Today, TELUS and the Victoria Cool Aid Society announced a new partnership through TELUS’ innovative mobile Health for Good program that will bring primary care to underserved people in the Victoria area. According to a 2020 survey1 studying Victoria’s homelessness and housing needs, over 1,500 individuals experience homelessness in Greater Victoria on any given night. These individuals face additional barriers outside of homelessness and are in need of health services including primary care, harm reduction services, and mental health supports. The Cool Aid Mobile Health Clinic, powered by TELUS Health, is a specially-equipped clinic on wheels that provides trauma-informed, primary medical treatments, mental health services, addiction support as well as COVID-19 assessments and testing directly to people who need it most.

“At TELUS, we believe that everyone should have access to healthcare when and where they need it, regardless of their socio-economic status. Through our partnership with Cool Aid, we are removing many of the barriers facing underserved and at-risk populations in the Victoria region by providing access to critical healthcare, social support, and COVID-19 testing,” said Darren Entwistle, President and CEO, TELUS. “As we continue to navigate the global pandemic, today’s expansion of our Health for Good program will enable us to care for our most marginalized citizens at a time when access to high-quality, compassionate healthcare, including vital support for mental wellness, has never been more important.”

The Mobile Health Clinic is equipped with TELUS Health’s electronic medical record (EMR) technology, TELUS Mobility services and TELUS LTE Wi-Fi network technology to assist the onboard care team in delivering immediate, quality care. Leveraging TELUS Health EMR technology, skilled practitioners will be able to collect and store data, examine results over time, and provide better continuity of care to patients who previously had undocumented medical histories.

“Bringing the Cool Aid Mobile Health Clinic to the Victoria region further expands our community health centre model of care and services for those who experience barriers to primary care and services,” said Mary Chudley, director of health and support services at Cool Aid. “Many marginalized communities including those who are under-housed or experience homelessness have not had access to primary care in years or do not have a documented medical history that can be referenced by healthcare practitioners. By facilitating better continuity of care, these services help those who cannot easily access traditional medical care, yet are in urgent need. With the mobile clinic, we are able to provide primary care to individuals who need complex care. This kind of outreach will ultimately lead to better patient outcomes.”

The vehicle is divided into two main areas: the first for patient reception and nursing care; and the second with an examination table and doctor’s workstation including equipment necessary to provide primary healthcare such as routine testing, contraception, STI treatment, harm reduction services, and mental health care and counselling. The clinic will also include:

  • Blood pressure machine with thermometer and pulse oximeter
  • Otoscope and ophthalmoscope
  • Emergency and harm reduction supplies
  • COVID-19 assessments and testing

Locations that the clinic will visit throughout Greater Victoria continue to be determined in collaboration with community partners to reach people in need where they are – in parks, shelters, supportive housing locations, soup kitchens, food banks, and on the streets. Staffed by a comprehensive team including physicians, nurse practitioners, registered nurses and outreach workers, the clinic will be able to deliver specialized care to the target population where and when they need it.

“By going to our clients instead of asking them to come to us, we get to step into their world and see the many barriers and challenges they are facing that may not be apparent when meeting with them in a more clinical setting,” said Robyn Kyle, Cool Aid Health outreach worker. “Part of what makes outreach workers so crucial, especially in a healthcare context, is that we have the tools to address those barriers and challenges, which inevitably leads to better healthcare engagement and better outcomes.”

Backed by a $10 million commitment from TELUS, the TELUS Health for Good program is active from coast-to-coast with clinics operating in Vancouver, Surrey, Edmonton, Ottawa, Mississauga-Peel Region, Waterloo Region, Montreal, Halifax and Toronto.

For more information about TELUS Health for Good, visit telus.com/healthforgood.

About TELUS Health for Good
Since 2014, TELUS Health for Good has been helping to remove many of the barriers Canadians living on the streets face in receiving medical care and reconnecting thousands of patients to the public healthcare system. The Mobile Health Clinics provide essential primary medical care, including electronic medical records, and have enabled over 70,000 patient visits since the program’s inception. Today, through numerous partnerships, volunteers, and the power of technology, TELUS Health for Good is an efficient and innovative mobile healthcare delivery tool to reach communities in need by bringing healthcare directly to the people that need it most.

About TELUS
TELUS (TSX: T, NYSE: TU) is a dynamic, world-leading communications technology company with $16 billion in annual revenue and 16 million customer connections spanning wireless, data, IP, voice, television, entertainment, video, and security. We leverage our global-leading technology and compassion to enable remarkable human outcomes. Our longstanding commitment to putting our customers first fuels every aspect of our business, making us a distinct leader in customer service excellence and loyalty. In 2020, TELUS was recognized as having the fastest wireless network in the world, reinforcing our commitment to provide Canadians with access to superior technology that connects us to the people, resources and information that make our lives better. TELUS Health is Canada’s leader in digital health technology, improving access to health and wellness services and revolutionizing the flow of health information across the continuum of care. TELUS Agriculture provides innovative digital solutions throughout the agriculture value chain, supporting better food outcomes from improved agri-business data insights and processes. TELUS International (TSX and NYSE: TIXT) is a leading digital customer experience innovator that delivers next-generation AI and content management solutions for global brands across the technology and games, ecommerce and FinTech, communications and media, healthcare, travel and hospitality sectors. TELUS and TELUS International operate in 25+ countries around the world. Together, let’s make the future friendly.

Driven by our passionate social purpose to connect all citizens for good, our deeply meaningful and enduring philosophy to give where we live has inspired TELUS, our team members and retirees to contribute more than $820 million and 1.6 million days of service since 2000. This unprecedented generosity and unparalleled volunteerism have made TELUS the most giving company in the world.

For more information about TELUS, please visit telus.com, follow us @TELUSNews on Twitter and @Darren_Entwistle on Instagram.

About the Victoria Cool Aid Society
The Victoria Cool Aid Society believes that everyone deserves home, health and community. We create opportunities for people who are homeless or living in poverty and we make a difference through housing, health and dental care, community, and emergency shelters. Founded in 1968, Cool Aid helps more than 12,000 people in the Capital region every year, at 20 locations in Victoria, Saanich and Langford, including more than 7,000 Community Health Centre patients. For more information about Cool Aid, visit coolaid.org.

Ontario Government funds new Virtual Intensive Treatment Program for Addiction at Renascent

$1.25M annualized investment addresses critical gap in the health care system by adding urgently needed intensive treatment for addiction using innovative virtual model.  

TORONTO, July 8, 2021 /CNW/ - The Ontario Government announced new annualized funding for Renascent in the amount of $1.25M, making a newly developed Virtual Intensive Outpatient Program (VIOP) for addiction available to Ontarians aged 16 years and older. The innovative new program was developed by Renascent over the course of the pandemic to address the lack of intensive treatment programs in the health care system and the rapidly growing wait times for addiction treatment.   

"With escalating rates of substance use and addiction across our communities, it is critical to ramp up the health care system's treatment capacity and look at incorporating innovative approaches to treatment," said Laura Bhoi, Chief Executive Officer, Renascent. "This new investment in Renascent's Virtual Intensive Outpatient Program adds urgently needed intensive outpatient treatment for Ontarians with substance use disorders, using a promising new virtual model."

To help meet the growing need for addiction treatment and services, Renascent – a not-for-profit organization – launched its Virtual Intensive Outpatient Program in April 2020. Through donations made to Renascent Foundation, the program has been offered to the public at no fee, already enabling over 200 people to access the intensive treatment.   

Clients who access the program receive 26 weeks of treatment, which includes six weeks of intensive programming, followed by 20 weeks of Continuing Care. There has been growing demand for the program over the last year, currently running with a waitlist and receiving high ratings from clients.  

"This new Government funding doubles the number of clients we can serve and most importantly, it supports us to operate this desperately needed program in a sustainable manner," said Bhoi. "Investment in this new virtual intensive treatment can build a new pathway for many individuals seeking help, as part of a larger system including inpatient, outpatient and harm reduction services."  

"I was given a second chance with Renascent – which transformed my life. The Virtual Intensive Outpatient Program helped me understand and process my experiences, gave me connections to others who understood what I was going through, and provided tools to help me abstain from drinking while remaining at home," said Pat S., former Renascent Virtual Intensive Outpatient Program client. "This was my first time participating in any type of virtual setting and I was pleased by how engaging it was. The counsellors were welcoming, and I was amazed at how quickly we all bonded. I am so grateful for my journey with Renascent, as being sober gives me a whole new perspective on life." 

In partnership with Ontario Shores' Research Team, the Virtual Intensive Outpatient Program will undergo formal program evaluation to assess outcomes and potential for its expansion. 

Anyone in need of addiction treatment is encouraged to contact Renascent directly. For more information about Renascent's Virtual Intensive Outpatient Program and other programs and services, visit: renascent.ca   

About Renascent and Renascent Foundation:
Renascent has been a trusted leader in the treatment of substance use and concurrent mental disorders for over 50 years; helping more than 50,000 people experiencing addiction on their road to recovery. Renascent is an accredited non-profit treatment centre, which provides hope and healing to individuals, families, loved ones, communities, and organizations impacted by addiction. Renascent Foundation enables the health and well-being of people experiencing addiction by inspiring investment into mental health and addictions programs and services.

SOURCE Renascent

Microbix Presenting Product Results to Industry

Two Abstracts Reporting on Cross-Platform Utility of Antigen & Serological QAPs™

MISSISSAUGA, Ontario, July 08, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it has been invited to present about the performance of its COVID-19 test quality assessment products (QAPs™) at “ECCMID 2021” the 31st annual congress organized by the European Society of Clinical Microbiology and Infectious Diseases, taking place in virtual format July 9-12, 2021.

The first abstract poster presentation is titled “Advanced SARS-CoV-2 nucleocapsid protein swab-based formulation for use as cross-platform EQA sample and as a prospective Quality Control.” It reviews the performance of Microbix’s novel, innovative, and proprietary REDx™FLOQ®, PROCEEDx™FLOQ®, and white-label SARS-CoV-2 Ag Swab Positive formulations that can be used to help ensure the accuracy of rapid “antigen-based” screening tests for COVID-19 disease. The results demonstrate that these Microbix QAPs are compatible with 32 widely-used COVID-19 antigen tests, including those from the world’s most prominent diagnostics companies.

The second abstract poster presentation is titled “Novel neutralizing anti-S1 SARS-CoV-2 human monoclonal antibody formulation for use as a cross-platform EQA sample and prospective quality controls.” It reviews the performance of Microbix’s pending QAPs to support the accuracy of tests for the presence and extent to which patients have developed protective and neutralizing antibodies to the virus causing COVID-19 disease, as a result of either vaccination or prior infection. The results demonstrate that these newly-created QAPs are compatible with four leading commercially-available COVID-19 S-Protein based neutralizing antibody “serology” tests, and do not have any cross-reactivity with two commercially-available COVID-19 N-Protein general “serology” tests.

Such results continue to demonstrate how Microbix is addressing the need for workflow controls to effectively support the quality objectives of all forms of testing relating to the pandemic, and with its QAPs portfolio now comprising more than 70 distinct products across multiple categories of infectious disease.

The abstract presentations were co-authored by ten members of Microbix’s product development (R&D), operating, and customer support teams, led by Pavel Zhelev, Director of Product Management (QAPs) and Dr. Amer Alagic, Director of R&D. The posters detail the performance results of the QAPs in a complete and succinct fashion. Both posters will be made available on the company website, https://microbix.com, upon their presentation at ECCMID 2021 and they include Microbix’s thankful acknowledgement of seventeen collaborator organizations in Canada and around the world.

Purchase enquiries for Microbix’s QAPs can be directed to one of its nine distributors for the Americas, Australasia, Europe, and Scandinavia, as cited later in this news release. QAPs product enquiries can also be e-mailed directly to Microbix at customer.service@microbix.com.

About Microbix Biosystems
Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales now approaching C$ 2.0 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Microbix antigens enable the antibody tests of over 100 international diagnostics companies, while its QAPs are sold to clinical laboratory accreditation organizations, diagnostics companies, and clinical laboratories. Microbix QAPs are now available in over 30 countries, distributed by 1WA (Oneworld Accuracy Inc.), Alpha-Tec Systems, Inc., Diagnostic International Distribution SpA., Labquality Oy, The Medical Supply Company of Ireland, R-Biopharm AG, SDT Molecular Pte Ltd, Seegene Canada Inc., and Thomas Scientific LLC. Microbix is ISO 9001 and 13485 accredited, U.S. FDA registered, Australian TGA registered, Health Canada establishment licensed, and provides CE marked products.

Microbix also applies its biological expertise and infrastructure to develop other proprietary products and technologies, most notably viral transport medium (DxTM™) to stabilize patient samples for lab-based molecular diagnostic testing and Kinlytic® urokinase, a biologic thrombolytic drug used to treat blood clots. Microbix is traded on the TSX and OTCQB, and headquartered in Mississauga, Ontario, Canada.

Forward-Looking Information
This news release includes “forward-looking information,” as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, discussion of the abstracts and their relevance, Microbix’s collaborators and their tests, the referenced product lines or their uses, Microbix’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced in its corporate presentation, regulatory compliance and approvals, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward-looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Pleas

Beazley launches innovative insurance solution for nutraceutical risks in Canada

Toronto, July 08, 2021 (GLOBE NEWSWIRE) -- Specialist insurer Beazley has launched its nutraceutical focused insurance product NutraGuard in Canada.

NutraGuard provides a dedicated insurance form customized for nutraceutical manufacturers and distributors with the flexibility to cover products liability, general liability, errors and omissions (E&O), product recall expense, employee benefits liability and hired/non-owned auto insurance. Coverage is available to companies active at all points of the nutraceutical value chain, from ingredient producers to product manufacturers to wholesale/retail distributors.

Derek Dow, Beazley healthcare underwriter, said: "With the Canadian nutraceuticals market expected to witness a growth rate of over 5% by 2024*, we see a gap within the insurance market for a policy tailored to the precise needs of this burgeoning market. Beazley NutraGuard offers a solution that responds to the wide variety of exposures that companies in this industry confront."

Evan Smith, Head of Miscellaneous Medical & Life Sciences at Beazley, said: "The expansion of our healthcare and life sciences offerings in Canada speaks volumes to the growth potential we see in this specialized insurance solution for businesses operating in the nutraceutical space. Beazley NutraGuard offers our clients a unique policy form that provides seamless coverage for the risks they face."

Beazley brings solid experience and understanding of the nutraceutical market having first launched NutraGuard in the US seven years ago.

With underwriters in the US, Canada, Latin America, UK, Europe and Asia Pacific, Beazley's growing healthcare team specializes in hard to place risks that require technical underwriting acumen. Clients include a wide range of organizations from producers of vitamins and minerals, lifestyle supplements, sports nutrition, cosmetics, personal care and energy products.

The risks that health-related organizations face are evolving fast as our recent research into changing attitudes to risk and insurance among digital health and wellness leaders demonstrates. Read our recent report here:

https://www.beazley.com/news/2021/digital_health_telehealth_and_wellness_attitudes_to_risk_and_insurance_revealed_in_new_research_published_by_beazley.html

https://www.reportlinker.com/p05865777/Canada-Nutraceuticals-Market-Growth-Trends-and-Forecasts.html?utm_source=GNW

Note to editors:

Beazley plc (BEZ.L) is the parent company of specialist insurance businesses with operations in Europe, United States, Canada, Latin America and Asia. Beazley manages six Lloyd’s syndicates and, in 2020, underwrote gross premiums worldwide of $3,563.8m. All Lloyd’s syndicates are rated A by A.M. Best. 

Beazley’s underwriters in the United States focus on writing a range of specialist insurance products. In the admitted market, coverage is provided by Beazley Insurance Company, Inc., an A.M. Best A rated carrier licensed in all 50 states. In the surplus lines market, coverage is provided by the Beazley syndicates at Lloyd’s.

Beazley’s European insurance company, Beazley Insurance dac, is regulated by the Central Bank of Ireland and is A rated by A.M. Best and A+ by Fitch.

Beazley is a market leader in many of its chosen lines, which include professional indemnity, cyber, property, marine, reinsurance, accident and life, and political risks and contingency business.

For more information please go to: www.beazley.com

New Book Celebrates the Power of God’s Love and Support During Daughter’s Caregiving Journey

Miraculous Encounter Affirms Evidence of God’s Presence in Trying Times

LOS ANGELES, CA, July 8, 2021 — Have you ever answered the call to care for a loved one in their final days? Imagine discovering that you are not alone when you are met with life’s most difficult challenges. That is exactly what happened to author Lisa Roseman when she experienced God’s reassuring daily presence during her journey as a caregiver for her mother.
 
In The Highest of Care: A Journey Through Cancer, Roseman offers hope in the face of terminal illness, denial and the reality of death. As she learned to navigate her new life as sole caregiver during her mother’s battle with cancer, she was faced with several challenges. The book details the healing journey of Roseman's relationship with her mother, rife with lack of communication and power struggles. Battling depression and exhaustion, she struggled to connect with her mother only to be met by rejection. With the patience of a saint, Roseman dedicated her life to her mother’s care, relying on God to help guide her in becoming the heart-centered caretaker her mother needed.

The book brings comfort to those navigating the challenges of caring for a loved one. Messages from God along the journey, including a message in the form of a lion on the wall above her mother’s bed, strengthened Roseman’s faith and affirmed that life is eternal. At the end of her mother’s life, she saw the lion reappear, gently guiding her mother into the afterlife. This profound experience facilitated a Divine awakening for Roseman, enveloped with God’s love.

As Roseman recalls, “I didn’t know that a book would come out of that 22-month-long season. It wasn’t until the end of her life, when a miracle happened, that I knew the story had to be told.” Through the powerful Christian prayer model she discovered years before, Sozo prayer, she broke through and found the courage and inner peace needed to continue caring for her mother and to begin practicing self-care.

The Highest of Care is filled with hope, reminding readers that messages from God are possible—in everyday life and in the miraculous—and all you need is to look for them.

About Lisa M. Roseman
Lisa M. Roseman, M.T.S., is a theologian, a lay counselor, and an author with the mission of assisting people toward transformation and inner healing—spiritually, emotionally and relationally. She is the founder of Sozo Freedom, an inner healing ministry in Southern California. Roseman has helped hundreds of people experience deep inner healing in various settings, including private mentorship, group counseling, addiction recovery and her church congregation.

For more information, please visit www.thehighestofcare.com. For information about Sozo prayer, visit www.sozofreedom.com. To view Lisa’s retelling of her vision of the lion on the wall, visit https://www.youtube.com/watch?v=NUTetbWMCjw.

The Highest of Care: A Journey Through Cancer
ISBN-13: ‎979-8726067780
Available from Amazon.com

##